BioStock: CLS presents study results and board changes - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Handla krypto: Nyfiken på krypto? Vi guidar dig och listar de bästa plattformarna för handel

Pressmeddelande

BioStock: CLS presents study results and board changes

Cision Publicerad: I förrgår 16:16
Clinical Laserthermia

Despite CLS’ decision to focus on commercialisation within neurosurgery, the company continues to present study results supporting the use of the TRANBERG system for the treatment of prostate cancer. Meanwhile, the company has announced a change in the board – Lars-Erik Eriksson, board member, former CEO, and co-founder, has decided to step down from his position. 

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/cls-presents-study-results-and-board-changes/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt